日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

A Phase II Study of Cabozantinib in Patients With MET-Altered Lung Cancers

卡博替尼治疗MET基因改变肺癌患者的II期研究

Harada, Guilherme; Santini, Fernando C; Wilhelm, Clare J; Repetti, Rebecca W; Chang, Jason C; Yang, Soo-Ryum; Lin, Yun-Te; Moses, Khadeja A; Falcon, Christina; Goldstein, Michelle; Makhnin, Alex; Ginsberg, Michelle S; Plodkowski, Andrew J; Kris, Mark G; Drilon, Alexander

Whole metagenome sequencing and 16S rRNA gene amplicon analyses reveal the complex microbiome responsible for the success of enhanced in-situ reductive dechlorination (ERD) of a tetrachloroethene-contaminated Superfund site

全宏基因组测序和16S rRNA基因扩增子分析揭示了促成四氯乙烯污染超级基金场地强化原位还原脱氯(ERD)成功的复杂微生物群落。

Reiss, Rebecca A; Guerra, Peter A; Makhnin, Oleg; Kellom, Matthew

A Phase I/II Study of Valemetostat (DS-3201b), an EZH1/2 Inhibitor, in Combination with Irinotecan in Patients with Recurrent Small-Cell Lung Cancer

Valemetostat (DS-3201b)(一种 EZH1/2 抑制剂)联合伊立替康治疗复发性小细胞肺癌患者的 I/II 期研究

Choudhury, Noura J; Lai, W Victoria; Makhnin, Alex; Heller, Glenn; Eng, Juliana; Li, Bob; Preeshagul, Isabel; Santini, Fernando C; Offin, Michael; Ng, Kenneth; Paik, Paul; Larsen, Christina; Ginsberg, Michelle S; Lau, Yvonne; Zhang, Xinyuan; Baine, Marina K; Rekhtman, Natasha; Rudin, Charles M

Brief Report: Combination of Osimertinib and Dacomitinib to Mitigate Primary and Acquired Resistance in EGFR-Mutant Lung Adenocarcinomas

简报:奥希替尼联合达可替尼治疗EGFR突变型肺腺癌的原发性和获得性耐药

Elkrief, Arielle; Makhnin, Alex; Moses, Khadeja A; Ahn, Linda S; Preeshagul, Isabel R; Iqbal, Afsheen N; Hayes, Sara A; Plodkowski, Andrew J; Paik, Paul K; Ladanyi, Marc; Kris, Mark G; Riely, Gregory J; Michor, Franziska; Yu, Helena A

Author Correction: Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer

作者更正:确定达可替尼和奥希替尼在晚期 EGFR 突变型非小细胞肺癌 I/II 期试验中的最佳给药方案

Poels, Kamrine E; Schoenfeld, Adam J; Makhnin, Alex; Tobi, Yosef; Wang, Yuli; Frisco-Cabanos, Heidie; Chakrabarti, Shaon; Shi, Manli; Napoli, Chelsi; McDonald, Thomas O; Tan, Weiwei; Hata, Aaron; Weinrich, Scott L; Yu, Helena A; Michor, Franziska

Tumor volume as a predictor of cell free DNA mutation detection in advanced non-small cell lung cancer

肿瘤体积作为晚期非小细胞肺癌中游离DNA突变检测的预测指标

Haseltine, Justin M; Offin, Michael; Flynn, Jessica R; Zhang, Zhigang; Lebow, Emily S; Aziz, Khaled; Makhnin, Alex; Eichholz, Jordan; Lim, Lee P; Li, Mark; Isbell, James M; Gomez, Daniel R; Li, Bob T; Rimner, Andreas

Multiplex SuperSelective PCR Assays for the Detection and Quantitation of Rare Somatic Mutations in Liquid Biopsies

多重超选择性 PCR 检测用于检测和定量液体活检中的罕见体细胞突变

Diana Y Vargas, Sanjay Tyagi, Salvatore A E Marras, Patricia Moerzinger, Juan A Abin-Carriquiry, Mauricio Cuello, Clara Rodriguez, Andrés Martinez, Alex Makhnin, Andrea Farina, Chintan Patel, Tuan L Chuang, Bob T Li, Fred R Kramer

Identification of optimal dosing schedules of dacomitinib and osimertinib for a phase I/II trial in advanced EGFR-mutant non-small cell lung cancer

确定达克替尼和奥希替尼在晚期 EGFR 突变型非小细胞肺癌 I/II 期试验中的最佳给药方案

Kamrine E Poels, Adam J Schoenfeld, Alex Makhnin, Yosef Tobi, Yuli Wang, Heidie Frisco-Cabanos, Shaon Chakrabarti, Manli Shi, Chelsi Napoli, Thomas O McDonald, Weiwei Tan, Aaron Hata, Scott L Weinrich, Helena A Yu, Franziska Michor

MET Exon 14-altered Lung Cancers and MET Inhibitor Resistance

MET 14号外显子改变的肺癌与MET抑制剂耐药性

Guo, Robin; Offin, Michael; Brannon, A Rose; Chang, Jason; Chow, Andrew; Delasos, Lukas; Girshman, Jeffrey; Wilkins, Olivia; McCarthy, Caroline G; Makhnin, Alex; Falcon, Christina; Scott, Kerry; Tian, Yuan; Cecchi, Fabiola; Hembrough, Todd; Alex, Deepu; Shen, Ronglai; Benayed, Ryma; Li, Bob T; Rudin, Charles M; Kris, Mark G; Arcila, Maria E; Rekhtman, Natasha; Paik, Paul; Zehir, Ahmet; Drilon, Alexander

Erlotinib and Trametinib in Patients With EGFR-Mutant Lung Adenocarcinoma and Acquired Resistance to a Prior Tyrosine Kinase Inhibitor

厄洛替尼和曲美替尼用于EGFR突变型肺腺癌且对先前酪氨酸激酶抑制剂产生耐药性的患者

Luo, Jia; Makhnin, Alex; Tobi, Yosef; Ahn, Linda; Hayes, Sara A; Iqbal, Afsheen; Ng, Kenneth; Arcila, Maria E; Riely, Gregory J; Kris, Mark G; Yu, Helena A